# FDA Inspection 1118502 - Sankyo Kasei Co., Ltd. - January 31, 2020

Source: https://www.keypedia.com/records/fda_inspections/sankyo-kasei-co-ltd/a3226d8a-9bac-4cd7-a73e-3d4a87dc94c5
Source feed: FDA_Inspections

> FDA Inspection 1118502 for Sankyo Kasei Co., Ltd. on January 31, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118502
- Company Name: Sankyo Kasei Co., Ltd.
- Inspection Date: 2020-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 694681 - 2010-09-16](https://www.keypedia.com/records/fda_inspections/sankyo-kasei-co-ltd/35c610a6-6635-4f89-84a3-dc9b105000a3)

Company: https://www.keypedia.com/companies/sankyo-kasei-co-ltd/b21f3e8a-e661-47f3-aa59-88efe73578c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c